Business context and reporting period
The supplied filing is Schweitzer-Mauduit International, Inc. (SWM), not Mativ Holdings, Inc. It is a Form 10-Q for the quarter and nine months ended September 30, 2014. SWM makes specialty papers, reconstituted tobacco products and filtration materials; its December 2013 acquisition of DelStar added the Filtration segment.
Financial results and liquidity
| Metric | Q3 2014 | Q3 2013 | Nine months 2014 | Nine months 2013 |
|---|---|---|---|---|
| Net sales | $204.3m | $185.3m | $612.6m | $576.3m |
| Gross profit / margin | $52.9m / 25.9% | $63.2m / 34.1% | $169.7m / 27.7% | $190.8m / 33.1% |
| Operating profit / margin | $25.2m / 12.3% | $41.8m / 22.6% | $88.8m / 14.5% | $125.6m / 21.8% |
| Net income | $23.0m | $29.1m | $71.2m | $85.8m |
| Diluted EPS | $0.76 | $0.92 | $2.32 | $2.72 |
| Cash provided by operations | $34.4m | $41.3m | $91.8m | $123.1m |
Q3 sales rose 10.3%, primarily because Filtration contributed $33.3m following the DelStar acquisition; lower volume, unfavorable product mix and pricing reduced sales by a combined $15.8m. For the nine months, sales rose 6.3%, including $97.1m from Filtration, while volume, mix and pricing reduced sales by $68.7m. Earnings and margins declined despite acquisition-related revenue growth.
Management attributed lower gross profit to reduced volumes, lower average selling prices, unfavorable mix and higher manufacturing costs, including production inefficiencies. Q3 interest expense was $1.8m versus $0.6m; nine-month expense was $5.4m versus $2.0m, reflecting higher debt after the DelStar acquisition and share repurchases. Effective tax rates were 8.8% for Q3 and 20.8% year to date, below prior-year rates of 33.1% and 31.6%, respectively, primarily due to discrete items and a greater concentration of earnings in lower-tax jurisdictions.
At September 30, 2014, cash was $286.0m, total debt $446.8m and long-term debt $437.9m. Current assets were $562.3m and current liabilities $136.4m. Credit-facility availability was $74.4m, with a further $44.5m available under bank overdraft facilities and lines of credit. Total debt to capital was 46.2%, up from 40.7% at year-end 2013. The company reported compliance with credit covenants. Of cash on hand, $278.7m was held by foreign subsidiaries.
Material changes versus prior comparable periods
- Nine-month operating profit fell 29.3% and net income fell 17.0%; diluted EPS declined from $2.72 to $2.32.
- Paper and Reconstituted Tobacco sales fell 6.9% and 19.8%, respectively, year to date. Filtration sales were $97.1m, reflecting DelStar, which was not in the prior-year comparison.
- Nine-month operating cash flow fell $31.3m, due to lower earnings and a larger working-capital cash use ($27.6m versus $16.0m). Higher receivables were a principal factor.
- Debt increased from $385.4m at December 31, 2013 to $446.8m. The company repurchased 1.16m shares for $52.5m and paid $33.0m in dividends during the first nine months.
- Foreign-currency translation reduced other comprehensive income by $39.6m year to date; total other comprehensive loss was $31.1m.
Outlook, commentary, risks and contingencies
Management expected tobacco-paper demand to face ongoing smoking-related attrition and pricing pressure, absent new LIP regulations. It identified South Korea as a possible next market for LIP rules, with a targeted July 2015 implementation; the estimated potential increase in global LIP paper demand was about 10%, but no outcome was assured. Management expected RTL volumes outside China to decline in 2015, while total RTL volumes could grow meaningfully when China joint-venture volumes are included. CTS began production in Q2 2014 and customer sales in mid-September; qualification, start-up expenses and a ramp toward full capacity by 2016 remained ahead. Filtration growth was expected to benefit from demand, particularly in water filtration, and potential commercial synergies.
2014 capital spending was projected at approximately $30m. The company expected $4.0m–$4.2m of spending related to the Spay, France voluntary departure and early-retirement program, with savings anticipated from the second half of 2014. Restructuring expense was $6.6m year to date and included the French program, Brazil severance and a loss on sale of the Lee Mills plant.
Brazilian tax disputes included approximately $41m of raw-material ICMS assessments, of which about $18m was covered by an indemnification, and approximately $19m of electricity-related assessments. No liability was recorded; SWM said it believed the matters would be resolved in its favor but gave no assurance of outcome. Environmental and other legal matters were also disclosed, without an expectation of material impact at the time of filing. The filing identified risks including tobacco-market decline, competitive and regulatory changes, input-cost inflation, foreign-exchange volatility, restructuring execution, acquisitions and joint-venture performance. Management reported disclosure controls were effective and no material change in internal control over financial reporting.
Most important facts for investors to verify
- Confirm the filing entity: the supplied 10-Q is for Schweitzer-Mauduit International, Inc., not Mativ Holdings, Inc.
- Assess whether DelStar’s contribution and expected filtration growth can offset continuing volume, mix and pricing pressure in Paper and Reconstituted Tobacco.
- Track manufacturing costs, production utilization, restructuring charges and whether the expected cost savings materialize.
- Monitor debt, covenant headroom, foreign-held cash accessibility and cash conversion as receivables and working capital change.
- Follow outcomes of the Brazilian ICMS assessments, the European patent proceedings, and CTS’s customer qualification and capacity ramp.